Skip to main content

Suicidal Ideation

0
Pipeline Programs
5
Companies
6
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
2 programs
Jaspr AppN/A1 trial
Jaspr App + JAHN/A1 trial
Active Trials
NCT06311591Enrolling By Invitation27,908Est. Jun 2027
NCT06223867Recruiting670Est. Mar 2028
Therapeutic Solutions International
1 program
Campbell ScoreN/A1 trial
Active Trials
NCT04606875Unknown30Est. Feb 2021
Innovation Pharmaceuticals
1 program
Group InterventionN/A1 trial
Active Trials
NCT01925807Completed76Est. May 2017
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Safe Alternatives for Teens and Youth-Acute for SchoolsN/A1 trial
Active Trials
NCT05834660Recruiting347Est. Aug 2025
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
ThriveN/A1 trial
Active Trials
NCT03595254Completed725Est. Apr 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Colorado TherapeuticsJaspr App
Colorado TherapeuticsJaspr App + JAH
Angeles TherapeuticsSafe Alternatives for Teens and Youth-Acute for Schools
Therapeutic Solutions InternationalCampbell Score
Human BioSciencesThrive
Innovation PharmaceuticalsGroup Intervention

Clinical Trials (6)

Total enrollment: 29,756 patients across 6 trials

NCT06311591Colorado TherapeuticsJaspr App

Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part B

Start: Nov 2024Est. completion: Jun 202727,908 patients
N/AEnrolling By Invitation
NCT06223867Colorado TherapeuticsJaspr App + JAH

Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A

Start: Feb 2024Est. completion: Mar 2028670 patients
N/ARecruiting
NCT05834660Angeles TherapeuticsSafe Alternatives for Teens and Youth-Acute for Schools

SAFETY-A for Promoting Equity in Suicide Prevention Outcomes in Schools

Start: Nov 2022Est. completion: Aug 2025347 patients
N/ARecruiting
NCT04606875Therapeutic Solutions InternationalCampbell Score

Correlation of Campbell Score With Suicidal Ideation

Start: Nov 2020Est. completion: Feb 202130 patients
N/AUnknown
NCT03595254Human BioSciencesThrive

Digital Cognitive Behavior Therapy Program for Suicide Prevention

Start: Nov 2018Est. completion: Apr 2020725 patients
N/ACompleted
NCT01925807Innovation PharmaceuticalsGroup Intervention

Building Resilience and Attachment in Vulnerable Adolescents

Start: Feb 2014Est. completion: May 201776 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 29,756 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.